Raising public awareness of MASH (metabolic dysfunction-associated steatohepatitis) and its precursor condition, MASLD (metabolic dysfunction-associated steatotic liver disease), is a top priority for Mount Sinai's MASLD/MASH Center of Excellence, as is leveraging its trove of data to find new ways to battle these serious hepatic diseases.